Prosecution Insights
Last updated: April 19, 2026

Examiner: MONTGOMERY, ANN Y

Tech Center 1600 • Art Units: 1641 1677 1678

This examiner grants 70% of resolved cases

Performance Statistics

69.6%
Allow Rate
+9.6% vs TC avg
681
Total Applications
+26.5%
Interview Lift
1419
Avg Prosecution Days
Based on 657 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
18.1%
§102 Novelty
44.3%
§103 Obviousness
17.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18469907 ARRAYS, SUBSTRATES, DEVICES, METHODS AND SYSTEMS FOR DETECTING TARGET MOLECULES Non-Final OA California Institute of Technology
17923594 CARRIER SYSTEM AND METHOD Non-Final OA CAMBRIDGE ENTERPRISE LIMITED
18269774 AUTOMATIC ANALYSIS DEVICE AND METHOD FOR CONTROLLING SAME Non-Final OA Hitachi High-Tech Corporation
17905675 NOVEL SPLIT-LUCIFERASE ENZYMES AND APPLICATIONS THEREOF Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17968259 SEPARATING APPARATUS OF BIOSUBSTANCE AND SEPARATING METHOD OF THE SAME Non-Final OA INVENTEC APPLIANCES CORPORATION
17908659 ELECTROMAGNETIC SAMPLING DEVICE PROTECTED IN A SEPTUM PIERCING NEEDLE Final Rejection DH TECHNOLOGIES DEVELOPMENT PTE. LTD.
18728404 CELL IMMOBILIZATION IN FLUID AT HIGH FLOW VELOCITIES Non-Final OA DYNAMIC BIOSENSORS GMBH
17575202 S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS Non-Final OA Roche Diagnostics Operations, Inc.
17281069 A detection method for detecting an oxidized LDL/Beta2GPI complex and a detection kit therefor Non-Final OA NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
18722188 METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA FROM BIOLOGICAL ASSAYS Non-Final OA The United States of America,as represented by the Secretary,Department of Health and Human Services
16855709 VIRUMETER FOR RAPID DETECTION OF COVID19 AND OTHER PATHOGENS Final Rejection Genesis Intelligence, LLC
17294358 DETECTION OF BLADDER CANCER Final Rejection Randox Laboratories Ltd.
17425150 ANTIGEN MEASURING METHOD AND MEASURING APPARATUS Non-Final OA PROVIGATE INC.
18251893 ACCURATE BULK FRET Non-Final OA Nanotemper Technologies GmbH
18006560 DEVELOPMENT OF A SMARTPHONE-BASED BIOSENSOR DEVICE FOR DETECTING SARS-COV-2 ANTIGENS IN BODY FLUIDS USING LOCALIZED SURFACE PLASMON RESONANCE (LSPR) Non-Final OA Minh Van PHAN
18017352 METHODS AND APPARATUS FOR DETECTING MOLECULES Non-Final OA INSTITUTE OF BIOPHYSICS OF THE CHINESE ACADEMY OF SCIENCES
18015086 METHOD FOR EVALUATING INTERACTION BETWEEN IMMOBILIZED SUBSTANCE IMMOBILIZED DIRECTLY OR INDIRECTLY ON SUBSTRATE AND PROXIMITY-DEPENDENT MODIFYING ENZYMELABELED SUBSTANCE TO BE ANALYZED Non-Final OA CELLFREE SCIENCES CO.,LTD.
17919508 FLUID HANDLING DEVICE AND METHODS Non-Final OA THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
18047799 SYSTEMS AND METHODS OF SIMPLE AND AUTOMATABLE PROTEIN DIGESTION USING MAGNETIC BEADS Non-Final OA Phenomenex, Inc.
17958264 DETECTION OF EXOSOMES AND EXOSOMAL BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS Non-Final OA NANOSOMIX, INC.
17772133 ANALYTE DETECTION AND QUANTIFICATION BY DISCRETE ENUMERATION OF PARTICLE COMPLEXES Non-Final OA Genotix Biotechnologies Inc.
14848032 MODULAR POINT-OF-CARE DEVICES, SYSTEMS, AND USES THEREOF Non-Final OA Labrador Diagnostics LLC
17607149 COMPOSITIONS AND METHODS FOR DETECTION OF DISEASE-RELATED ANTIBODY Non-Final OA Li LIU
15035223 Quantitative Controls and Calibrators for Cellular Analytes Non-Final OA BOSTON CELL STANDARDS LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month